NCT04569955

Brief Summary

  • Clinical trials are essential to translate new therapy concepts or rather any intervention into the medical routine. Beside the well designed trial protocol, the success of clinical trials depends on patient recruitment and participation.
  • This study aims to get a current picture of the patients' knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

July 20, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 30, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

September 30, 2020

Status Verified

September 1, 2020

Enrollment Period

4 months

First QC Date

July 7, 2020

Last Update Submit

September 28, 2020

Conditions

Breast CancerClinical Trials

Outcome Measures

Primary Outcomes (1)

  • The percentage of breast cancer patients who accept to participate in clinical trials

    1 year

Secondary Outcomes (1)

  • The barriers for participation in clinical trials

    1 year

Interventions

Knowledge and perception of clinical trial participationBEHAVIORAL

This study aims to get a current picture of the patients' knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries

Eligibility Criteria

AgeUp to 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

-Egyptian female Breast cancer patients

You may qualify if:

  • Female breast cancer patients

You may not qualify if:

  • Patients who refuse participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain shams university, faculty of medicine

Cairo, Select, 1667, Egypt

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Hagar Elghazawy

    Ain shams university, faculty of medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hagar Elghazawy, MD

CONTACT

01006232406dr.hagar.elghazawy@med.asu.edu.eg

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of clinical oncology

Study Record Dates

First Submitted

July 7, 2020

First Posted

September 30, 2020

Study Start

July 20, 2020

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

September 30, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)